Rubius Therapeutics Inc
(RUBY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -179,666 | -159,526 | -96,653 | -52,412 | -196,547 |
| Depreciation Amortization | 6,254 | 5,827 | 3,158 | 1,559 | 7,723 |
| Accounts payable and accrued liabilities | -9,811 | -2,551 | 638 | 124 | 5,858 |
| Other Working Capital | -17,525 | 872 | -1,442 | -4,721 | 6,694 |
| Other Operating Activity | 50,606 | 37,753 | 12,878 | 8,315 | 31,150 |
| Operating Cash Flow | $-150,142 | $-117,625 | $-81,421 | $-47,135 | $-145,122 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,626 | -78,445 | -78,445 | -78,445 | N/A |
| PPE Investments | 12,639 | -5,038 | -4,165 | -2,402 | -3,649 |
| Sale Of Investment | 83,931 | 78,750 | N/A | N/A | 85,000 |
| Investing Cash Flow | $12,944 | $-4,733 | $-82,610 | $-80,847 | $81,351 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -75,702 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 232 | 232 | 232 | 76 | 10,963 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 187,490 |
| Financing Cash Flow | $-75,470 | $232 | $232 | $76 | $198,453 |
| Beginning Cash Position | 227,583 | 227,583 | 227,583 | 227,583 | 92,901 |
| End Cash Position | 14,915 | 105,457 | 63,784 | 99,677 | 227,583 |
| Net Cash Flow | $-212,668 | $-122,126 | $-163,799 | $-127,906 | $134,682 |
| Free Cash Flow | |||||
| Operating Cash Flow | -150,142 | -117,625 | -81,421 | -47,135 | -145,122 |
| Capital Expenditure | -5,304 | -5,038 | -4,165 | -2,402 | -3,649 |
| Free Cash Flow | -155,446 | -122,663 | -85,586 | -49,537 | -148,771 |